Difficulty: Medium
Average Score: 66%
Practice
A 42-year-old woman with bilateral metastatic breast cancer undergoes surgery followed by radiation and a cycle of chemotherapy. PET scan still reveals the presence of metastatic disease. She undergoes therapy with a novel chemotherapy agent capecitabine. This medication works through inhibition of which of the following?
Correct answer
D
Rationale
The correct answer is D) Thymidylate synthase. Capecitabine is a prodrug that is converted to 5-fluorouracil (5-FU) in the body. 5-FU is an antimetabolite that inhibits thymidylate synthase, an enzyme necessary for DNA synthesis. By inhibiting thymidylate synthase, 5-FU disrupts DNA replication in rapidly dividing cancer cells, leading to cell death.
Option A) DNA synthase is incorrect because there is no enzyme known as DNA synthase. DNA is synthesized by DNA polymerase.
Option B) RNA polymerase is incorrect because capecitabine does not target RNA synthesis. It specifically inhibits DNA synthesis by targeting thymidylate synthase.
Option C) RNA transferase is incorrect because this term is not a recognized enzyme involved in DNA or RNA synthesis. It seems to be a combination of RNA polymerase and transfer RNA (tRNA), which are not targeted by capecitabine.
Educationally, understanding the mechanism of action of chemotherapy drugs like capecitabine is crucial for healthcare providers to make informed decisions about treatment options for patients with cancer. Knowing how specific drugs target cancer cells can help in predicting and managing potential side effects and assessing treatment efficacy.
Option A) DNA synthase is incorrect because there is no enzyme known as DNA synthase. DNA is synthesized by DNA polymerase.
Option B) RNA polymerase is incorrect because capecitabine does not target RNA synthesis. It specifically inhibits DNA synthesis by targeting thymidylate synthase.
Option C) RNA transferase is incorrect because this term is not a recognized enzyme involved in DNA or RNA synthesis. It seems to be a combination of RNA polymerase and transfer RNA (tRNA), which are not targeted by capecitabine.
Educationally, understanding the mechanism of action of chemotherapy drugs like capecitabine is crucial for healthcare providers to make informed decisions about treatment options for patients with cancer. Knowing how specific drugs target cancer cells can help in predicting and managing potential side effects and assessing treatment efficacy.